Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 675 of 1467 entries
View as:

Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Phase: N/A Priority: Normal
NCT ID: NCT03194867 Org: User:
Start: 02/21/18 End: 04/05/23 Due: 04/05/24

Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01572649 Org: User:
Start: 05/31/12 End: 03/31/14 Due: 03/31/15

Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT01367444 Org: User:
Start: 06/08/11 End: 08/16/19 Due: 08/16/20

Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Drugs

Phase: N/A Priority: Normal
NCT ID: NCT02752412 Org: User:
Start: 05/17/16 End: 10/04/18 Due: 10/04/19

A Study in Healthy Adult Male & Female Participants to Assess the Amount of the Study Medicine (SAR443820) Absorbed by the Body, When Given Orally in Fasted Condition as a Tablet Versus as a Capsule (Part 1) and When Given Orally as a Tablet in Fasted Condition Versus as a Tablet After Food (Part 2)

Phase: N/A Priority: Normal
NCT ID: NCT05797701 Org: User:
Start: 07/28/21 End: 09/06/21 Due: 09/06/22

The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)

Phase: N/A Priority: Normal
NCT ID: NCT00069784 Org: User:
Start: 08/31/03 End: 12/31/11 Due: 12/31/12

A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic Therapies

Phase: N/A Priority: Normal
NCT ID: NCT06616415 Org: User:
Start: 12/04/24 End: 05/13/26 Due: 05/13/27

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT06141473 Org: User:
Start: 12/13/23 End: 05/06/27 Due: 05/06/28

20 Week Bridging Study in Type II DM

Phase: N/A Priority: Normal
NCT ID: NCT00563225 Org: User:
Start: 10/31/02 End: 04/30/04 Due: 04/30/05

Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites

Phase: N/A Priority: Normal
NCT ID: NCT00327444 Org: User:
Start: 07/31/06 End: 10/31/09 Due: 10/31/10

A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01755390 Org: User:
Start: 10/31/99 End: 10/31/02 Due: 10/31/03

Fasturtec TLS Treatment / Prophylysis

Phase: N/A Priority: Normal
NCT ID: NCT00651911 Org: User:
Start: 07/31/03 End: 07/31/04 Due: 07/31/05

An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Phase: N/A Priority: Normal
NCT ID: NCT00250601 Org: User:
Start: 04/30/05 End: 07/31/07 Due: 07/31/08

Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00811395 Org: User:
Start: 10/31/07 End: 04/30/10 Due: 04/30/11

Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00425191 Org: User:
Start: 07/31/02 End: - Due: -

Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid)- Compatibility

Phase: N/A Priority: Normal
NCT ID: NCT00784160 Org: User:
Start: 07/31/08 End: 09/30/08 Due: 09/30/09

Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor Patients

Phase: N/A Priority: Normal
NCT ID: NCT01657214 Org: User:
Start: 09/30/12 End: 01/31/16 Due: 01/31/17

Interaction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV Patients

Phase: N/A Priority: Normal
NCT ID: NCT01690403 Org: User:
Start: 12/31/12 End: 03/31/14 Due: 03/31/15

A First-in-human Single and Repeated Dose Escalation Study of SAR442501 in Healthy Adults Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05846009 Org: User:
Start: 11/18/20 End: 01/12/22 Due: 01/12/23

Long-Term Effect of 10 mg Versus 20 mg Rimonabant in Overweight or Obese Patients

Phase: N/A Priority: Normal
NCT ID: NCT00678483 Org: User:
Start: 04/30/08 End: 02/28/09 Due: 02/28/10

Dermatological Evaluation of Topic Compatibility-Dermacyd Delicata Pocket BR

Phase: N/A Priority: Normal
NCT ID: NCT00668460 Org: User:
Start: 11/30/07 End: - Due: -

Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS)

Phase: N/A Priority: Normal
NCT ID: NCT00434096 Org: User:
Start: 02/28/07 End: 02/28/09 Due: 02/28/10

CARE Canadian ALS Riluzole Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT00542412 Org: User:
Start: 01/31/01 End: 12/31/04 Due: 12/31/05

Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)

Phase: N/A Priority: Normal
NCT ID: NCT04550962 Org: User:
Start: 11/02/20 End: 07/01/26 Due: 07/01/27

Ramipril 10 mg/Day Prevention

Phase: N/A Priority: Normal
NCT ID: NCT01053910 Org: User:
Start: 10/31/03 End: - Due: -